Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02626559 · ClinicalTrials.gov registry record
Serum Bupivacaine Concentration Levels After Injection of Liposomal Bupivacaine Into the Knee
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 40
- Enrollment target
NCT02626559 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 40 participants.
The verdict
NCT02626559 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Serum levels of bupivacaine over time after peri-articular injection of a mixture of liposomal bupivacaine and plain bupivacaine during total knee arthroplasty.
Interventions
- DRUG liposomal bupivacaine/plain bupivacaine peri-articular injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02626559
The ClinicalTrials.gov registry entry for NCT02626559 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which liposomal bupivacaine/plain bupivacaine peri-articular injection is the first listed.
NCT02626559 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02626559 about?
NCT02626559 is a clinical study titled "Serum Bupivacaine Concentration Levels After Injection of Liposomal Bupivacaine Into the Knee". Serum levels of bupivacaine over time after peri-articular injection of a mixture of liposomal bupivacaine and plain bupivacaine during total knee arthroplasty.
What is the current status of trial NCT02626559?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2015-11. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02626559?
The interventions under investigation include: liposomal bupivacaine/plain bupivacaine peri-articular injection (DRUG).
Who is sponsoring clinical trial NCT02626559?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.